3 recruiting, 1 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 3, Completed 1 |
Follow Thyroid Eye Disease, TED: new trials by email Literature Review of Thyroid Eye Disease, TED trials Research Report on Thyroid Eye Disease, TED
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study MHB018A, MHB018A placebo - Thyroid Eye Disease, TED | Phase 3 | Recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 84 | 2026-09-28 | 2026-10-14 |
| Treatment of Chronic Thyroid Eye Disease With MHB018A MHB018A injection, MHB018A injection Placebo - Thyroid Eye Disease, TED | Phase 3 | Recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 135 | 2026-09-24 | 2026-10-14 |
| Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED) linsitinib, Placebo - Thyroid Eye Disease, TED, Graves Orbitopathy | Phase 3 | Recruiting | Sling Therapeutics, Inc. | 130 | 2026-08-04 | 2026-10-20 |
| A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease IBI311 - Thyroid Eye Disease, TED | Phase 3 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 91 | 2023-10-20 | 2026-05-01 |
Graves Ophthalmopathy (4) · Graves Disease (1) · Hashimoto Disease (1)
Autoimmune Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Endocrine System Diseases (4) · Exophthalmos (4) · Eye Diseases (4) · Eye Diseases, Hereditary (4) · Genetic Diseases, Inborn (4) · Goiter (4) · Hyperthyroidism (4) · Immune System Diseases (4) · Orbital Diseases (4) · Thyroid Diseases (4) · Graves Disease (3) · Thyroiditis (1) · Thyroiditis, Autoimmune (1)
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (1)
Minghui Pharmaceutical (Hangzhou) Ltd (2) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Sling Therapeutics, Inc. (1)
United States (3) · China (1)